Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast
October 29, 2024
Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 7, 2024
Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks
October 2, 2024
Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed
September 27, 2024
Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital
September 27, 2024
Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules
September 27, 2024
Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
September 23, 2024
Beyond Air® Reports Fiscal First Quarter 2025 Financial Results and Provides Corporate Update
August 6, 2024
Beyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia
July 31, 2024
Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6
July 23, 2024

Sign up for updates from Beyond Air, Inc.

Unsubscribe from all email communications. Unsubscribe